India · Delayed Price · Currency is INR NSE:KREBSBIO Statistics
Total Valuation
NSE:KREBSBIO has a market cap or net worth of INR 1.24 billion. The enterprise value is 3.46 billion.
| Market Cap | 1.24B |
| Enterprise Value | 3.46B |
Important Dates
The last earnings date was Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 21.56M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.40 |
| PB Ratio | -0.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.11 |
| EV / Sales | 15.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -15.12% |
| Return on Capital Employed (ROCE) | -30.09% |
| Weighted Average Cost of Capital (WACC) | 3.54% |
| Revenue Per Employee | 1.14M |
| Profits Per Employee | -1.13M |
| Employee Count | 202 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:KREBSBIO has paid 153,000 in taxes.
| Income Tax | 153,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.85% in the last 52 weeks. The beta is 0.23, so NSE:KREBSBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -28.85% |
| 50-Day Moving Average | 64.03 |
| 200-Day Moving Average | 73.06 |
| Relative Strength Index (RSI) | 47.95 |
| Average Volume (20 Days) | 12,024 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:KREBSBIO had revenue of INR 230.23 million and -228.62 million in losses. Loss per share was -10.60.
| Revenue | 230.23M |
| Gross Profit | 176.89M |
| Operating Income | -163.37M |
| Pretax Income | -228.47M |
| Net Income | -228.62M |
| EBITDA | -98.90M |
| EBIT | -163.37M |
| Loss Per Share | -10.60 |
Balance Sheet
The company has 1.48 million in cash and 2.21 billion in debt, with a net cash position of -2.21 billion.
| Cash & Cash Equivalents | 1.48M |
| Total Debt | 2.21B |
| Net Cash | -2.21B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.61B |
| Book Value Per Share | -74.59 |
| Working Capital | -1.02B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.83%, with operating and profit margins of -70.96% and -99.30%.
| Gross Margin | 76.83% |
| Operating Margin | -70.96% |
| Pretax Margin | -99.23% |
| Profit Margin | -99.30% |
| EBITDA Margin | -42.96% |
| EBIT Margin | -70.96% |
| FCF Margin | n/a |
Dividends & Yields
NSE:KREBSBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.03% |
| Earnings Yield | -18.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |